Gastroenterology
Volume 137, Issue 3 , Page 1179 , September 2009

Terlipressin for Hepatorenal Syndrome: Continuous Infusion as an Alternative to IV Bolus Administration

References 

  1. Martín-Llahi M, Pépin MN, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008;134:1352–1359
  2. Sanyal AJ, Boyer T, Garcia-Tsao G, et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology. 2008;134:1360–1368
  3. Lim JK, Groszmann RJ. Vasoconstrictor therapy for the hepatorenal syndrome. Gastroenterology. 2008;134:1608–1611
  4. Arroyo V, Ginès P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis (International Ascites Club). Hepatology. 1996;23:164–176
  5. Salerno F, Gerbes AL, Ginès P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56:1310–1318

 Conflicts of interest The authors disclose no conflicts.

PII: S0016-5085(09)01144-5

doi: 10.1053/j.gastro.2009.03.064

Gastroenterology
Volume 137, Issue 3 , Page 1179 , September 2009

Article Tools